UPDATE: J.P. Morgan Initiates Coverage On Albany Molecular Research, Inc. As Increasingly Relevant Competitor
J.P. Morgan Reinstates Underweight Rating on Myriad Over LT Outlook Concerns
UPDATE: J.P. Morgan Upgrades Accuray on Multiple Positive Factors
UPDATE: J.P. Morgan Initiates Cellular Dynamics with Overweight on Market Leader Position